More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
The patented product, developed by Venus Medicine Research Centre (VMRC) for the treatment of multidrug-resistant (MDR) infections, was sold to Cipla in 2019
While Merck can appeal, Halozyme said it expects the order to hold
Captured microbes are then neutralized on engineered microbicidal surfaces
Growing patent filings and tier-2 innovators reflect expanding national research base
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
StarGuide GX delivers ultra-high sensitivity and high-resolution imaging, enabling fast, confident diagnostics
Subscribe To Our Newsletter & Stay Updated
